Teladoc Health (TDOC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $5.67, -5.03% vs the prior close of $5.97.
- Volume 2.93M shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TDOC slides 5.0% to $5.67. Closed at $5.67, -5.03% vs the prior close of $5.97. Day range $5.64–$6.03, opened at $6.02.
TDOC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — TDOC slides 5.0% to $5.67
- Closed at $5.67, -5.03% vs the prior close of $5.97. Day range $5.64–$6.03, opened at $6.02.
- Volume was 2.93M shares, 0.8x its 50-day average of 3.59M.
- Price is -9.0% vs its 50-day average ($6.23) and -12.7% vs its 200-day average ($6.50).
- 52-week range $4.40–$9.89; today's close sits at 23% of that range, 42.7% below the 52-week high.
Oct 15, 2026 — TDOC rises 2.8% to $5.97
- Closed at $5.97, +2.75% vs the prior close of $5.81. Day range $5.76–$5.98, opened at $5.85.
- Volume was 2.93M shares, 0.8x its 50-day average of 3.65M.
- Price is -4.5% vs its 50-day average ($6.25) and -8.2% vs its 200-day average ($6.50).
- 52-week range $4.40–$9.89; today's close sits at 29% of that range, 39.6% below the 52-week high.
Oct 14, 2026 — TDOC slides 3.2% to $5.81
- Closed at $5.81, -3.17% vs the prior close of $6.00. Day range $5.71–$5.96, opened at $5.81.
- Volume was 3.51M shares, 0.9x its 50-day average of 3.70M.
- Price is -7.3% vs its 50-day average ($6.27) and -10.7% vs its 200-day average ($6.51).
- 52-week range $4.40–$9.89; today's close sits at 26% of that range, 41.2% below the 52-week high.
Oct 13, 2026 — TDOC rises 1.4% to $6.00, 3 up days in a row
- Closed at $6.00, +1.35% vs the prior close of $5.92. Day range $5.88–$6.18, opened at $5.93.
- Volume was 4.28M shares, 1.1x its 50-day average of 3.76M.
- Price is -4.6% vs its 50-day average ($6.29) and -7.9% vs its 200-day average ($6.51).
- 52-week range $4.40–$9.89; today's close sits at 29% of that range, 39.3% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — TDOC rises 2.6% to $5.92
- Closed at $5.92, +2.60% vs the prior close of $5.77. Day range $5.73–$5.98, opened at $5.82.
- Volume was 3.25M shares, 0.8x its 50-day average of 3.87M.
- Price is -6.1% vs its 50-day average ($6.30) and -9.2% vs its 200-day average ($6.52).
- 52-week range $4.40–$9.89; today's close sits at 28% of that range, 40.1% below the 52-week high.
Oct 9, 2026 — TDOC jumps 4.2% to $5.77
- Closed at $5.77, +4.15% vs the prior close of $5.54. Day range $5.49–$5.80, opened at $5.52.
- Volume was 4.18M shares, 1.0x its 50-day average of 4.31M.
- Price is -8.7% vs its 50-day average ($6.32) and -11.6% vs its 200-day average ($6.53).
- 52-week range $4.40–$9.89; today's close sits at 25% of that range, 41.6% below the 52-week high.
Oct 8, 2026 — TDOC dips 0.4% to $5.54, 3 down days in a row
- Closed at $5.54, -0.36% vs the prior close of $5.56. Day range $5.42–$5.55, opened at $5.50.
- Volume was 4.67M shares, 1.1x its 50-day average of 4.38M.
- Price is -12.5% vs its 50-day average ($6.33) and -15.2% vs its 200-day average ($6.53).
- 52-week range $4.40–$9.89; today's close sits at 21% of that range, 44.0% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — TDOC slides 3.6% to $5.56
- Closed at $5.56, -3.64% vs the prior close of $5.77. Day range $5.53–$5.76, opened at $5.76.
- Volume was 3.62M shares, 0.8x its 50-day average of 4.41M.
- Price is -13.2% vs its 50-day average ($6.41) and -15.0% vs its 200-day average ($6.54).
- 52-week range $4.40–$9.89; today's close sits at 21% of that range, 43.8% below the 52-week high.
Oct 6, 2026 — TDOC dips 0.3% to $5.77
- Closed at $5.77, -0.35% vs the prior close of $5.79. Day range $5.68–$5.85, opened at $5.82.
- Volume was 3.72M shares, 0.8x its 50-day average of 4.40M.
- Price is -11.0% vs its 50-day average ($6.48) and -11.9% vs its 200-day average ($6.55).
- 52-week range $4.40–$9.89; today's close sits at 25% of that range, 41.6% below the 52-week high.
Oct 5, 2026 — TDOC jumps 4.9% to $5.79
- Closed at $5.79, +4.89% vs the prior close of $5.52. Day range $5.48–$5.81, opened at $5.50.
- Volume was 4.47M shares, 1.0x its 50-day average of 4.40M.
- Price is -11.5% vs its 50-day average ($6.55) and -11.7% vs its 200-day average ($6.56).
- 52-week range $4.40–$9.89; today's close sits at 25% of that range, 41.4% below the 52-week high.
Oct 2, 2026 — TDOC dips 2.6% to $5.52, a 3-month low
- Closed at $5.52, -2.65% vs the prior close of $5.67. Day range $5.48–$5.74, opened at $5.74.
- Volume was 4.89M shares, 1.1x its 50-day average of 4.40M.
- Price is -16.4% vs its 50-day average ($6.61) and -15.9% vs its 200-day average ($6.57).
- 52-week range $4.40–$9.89; today's close sits at 20% of that range, 44.2% below the 52-week high.
TDOC latest news & SEC filings
Every SEC filing by or about TDOC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Catapano Joseph Ronald converted options/RSUs into 2,083 shares on Oct 1, 2026; now holds 14,948
- Catapano Joseph Ronald sold 655 shares at $5.65 (≈$3.70K) on Oct 2, 2026; now holds 14,293
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Divita Charles Iii sold 17,805 shares at $6.10 (≈$108.61K) on Sep 11, 2026
- Divita Charles Iii sold 17,805 shares at $6.10 (≈$108.61K) on Sep 11, 2026
- Divita Charles Iii sold 17,805 shares at $6.10 (≈$108.61K) on Sep 11, 2026
- Divita Charles Iii sold 17,805 shares at $6.10 (≈$108.61K) on Sep 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Nueno Carlos sold 6,200 shares at $6.30 (≈$39.06K) on Sep 2, 2026
- Nueno Carlos sold 6,200 shares at $6.30 (≈$39.06K) on Sep 2, 2026
- Nueno Carlos sold 6,200 shares at $6.30 (≈$39.06K) on Sep 2, 2026
- Nueno Carlos sold 6,200 shares at $6.30 (≈$39.06K) on Sep 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Vandervoort Adam C sold 7,573 shares at $6.30 (≈$47.71K) on Sep 2, 2026
- Vandervoort Adam C sold 7,573 shares at $6.30 (≈$47.71K) on Sep 2, 2026
- Vandervoort Adam C sold 7,573 shares at $6.30 (≈$47.71K) on Sep 2, 2026
- Vandervoort Adam C sold 7,573 shares at $6.30 (≈$47.71K) on Sep 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 31, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 30, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $606.93M (prior year $631.90M) (-4.0% vs Jun 30, 2025)
- Net income: -$38.91M (prior year -$32.66M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.21 (prior year -$0.19) (loss widened vs Jun 30, 2025)
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 22, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade TDOC
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: Apr 29, 2026, Feb 25, 2026, Oct 29, 2025. Based on that rhythm, the next report is likely around Oct 28, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.29% (largest 5.0%).
- Liquidity: about 3.61M shares (≈$20.46M) trade per day on average.
- 52-week position: $5.67 vs a range of $4.40–$9.89 (23% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Charles Iii Divita sold 17,805 shares on Sep 11, 2026.
- Latest filings: 8-K Sep 25, 2026; 8-K Aug 31, 2026; 8-K Aug 13, 2026.
- Share count: 181.68M shares outstanding (Jul 23, 2026), +2.8% vs a year earlier.
- Listing: NYSE · industry: Services-Offices & Clinics of Doctors of Medicine.
TDOC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.02 | 6.03 | 5.64 | 5.67 | 2.93M |
| Oct 15, 2026 | 5.85 | 5.98 | 5.76 | 5.97 | 2.93M |
| Oct 14, 2026 | 5.81 | 5.96 | 5.71 | 5.81 | 3.51M |
| Oct 13, 2026 | 5.93 | 6.18 | 5.88 | 6.00 | 4.28M |
| Oct 12, 2026 | 5.82 | 5.98 | 5.73 | 5.92 | 3.25M |
| Oct 9, 2026 | 5.52 | 5.80 | 5.49 | 5.77 | 4.18M |
| Oct 8, 2026 | 5.50 | 5.55 | 5.42 | 5.54 | 4.67M |
| Oct 7, 2026 | 5.76 | 5.76 | 5.53 | 5.56 | 3.62M |
| Oct 6, 2026 | 5.82 | 5.85 | 5.68 | 5.77 | 3.72M |
| Oct 5, 2026 | 5.50 | 5.81 | 5.48 | 5.79 | 4.47M |
| Oct 2, 2026 | 5.74 | 5.74 | 5.48 | 5.52 | 4.89M |
| Oct 1, 2026 | 5.87 | 5.93 | 5.65 | 5.67 | 3.42M |
| Sep 30, 2026 | 5.81 | 5.92 | 5.75 | 5.80 | 3.41M |
| Sep 29, 2026 | 5.86 | 5.90 | 5.71 | 5.75 | 3.74M |
| Sep 28, 2026 | 6.05 | 6.07 | 5.85 | 5.89 | 4.15M |
| Sep 25, 2026 | 6.10 | 6.18 | 5.97 | 6.09 | 3.02M |
| Sep 24, 2026 | 6.19 | 6.24 | 6.07 | 6.14 | 3.02M |
| Sep 23, 2026 | 6.28 | 6.32 | 6.11 | 6.13 | 2.97M |
| Sep 22, 2026 | 6.34 | 6.47 | 6.22 | 6.35 | 2.99M |
| Sep 21, 2026 | 6.36 | 6.38 | 6.22 | 6.27 | 3.00M |
About Teladoc Health
Teladoc Health (TDOC) is listed on the NYSE and classified by the SEC under “Services-Offices & Clinics of Doctors of Medicine”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1477449.
TDOC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Mark V Anquillare | Director | Aug 4, 2026 |
| Charles Iii Divita | CHIEF EXECUTIVE OFFICER | Sep 14, 2026 |
| Jason Eric Evans | Director | Dec 22, 2025 |
| Sandra L Fenwick | Director | May 21, 2026 |
| Catherine Jacobson | Director | May 21, 2026 |
| Kenneth H Paulus | Director | May 21, 2026 |
| Susan R Salka | Director | Apr 1, 2026 |
| David L Shedlarz | Director | May 21, 2026 |
| David B Jr Snow | Director | May 21, 2026 |
| Mark Douglas Smith | Director | May 21, 2026 |
| Michael S Smith | Director | Feb 19, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kelly Bliss | President, U.S. Group Health | Sep 3, 2026 |
| Joseph Ronald Catapano | Chief Accounting Officer | Sep 3, 2026 |
| Charles Iii Divita | CHIEF EXECUTIVE OFFICER | Sep 14, 2026 |
| Michael F Grasher | Chief Financial Officer | Sep 1, 2026 |
| Carlos Nueno | President, International | Sep 3, 2026 |
| Fernando M. Rodrigues | President of BetterHelp | Sep 3, 2026 |
| Adam C Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | Sep 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Charles Iii Divita | Sale | 17,805 | $6.10 |
| Sep 11, 2026 | Charles Iii Divita | Sale | 17,805 | $6.10 |
| Sep 11, 2026 | Charles Iii Divita | Sale | 17,805 | $6.10 |
| Sep 11, 2026 | Charles Iii Divita | Sale | 17,805 | $6.10 |
| Sep 3, 2026 | Fernando M. Rodrigues | Sale | 9,812 | $6.51 |
| Sep 3, 2026 | Fernando M. Rodrigues | Sale | 9,812 | $6.51 |
| Sep 3, 2026 | Fernando M. Rodrigues | Sale | 9,812 | $6.51 |
| Sep 3, 2026 | Fernando M. Rodrigues | Sale | 9,812 | $6.51 |
| Sep 2, 2026 | Charles Iii Divita | Sale | 18,327 | $6.30 |
| Sep 2, 2026 | Charles Iii Divita | Sale | 18,327 | $6.30 |
| Sep 2, 2026 | Charles Iii Divita | Sale | 18,327 | $6.30 |
| Sep 2, 2026 | Charles Iii Divita | Sale | 18,327 | $6.30 |
| Sep 2, 2026 | Adam C Vandervoort | Sale | 7,573 | $6.30 |
| Sep 2, 2026 | Adam C Vandervoort | Sale | 7,573 | $6.30 |
| Sep 2, 2026 | Adam C Vandervoort | Sale | 7,573 | $6.30 |
TDOC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.53B | $-200.32M | -1.14 | $294.36M |
| Dec 31, 2024 | $2.57B | $-1.00B | -5.87 | $293.68M |
| Dec 31, 2023 | $2.60B | $-220.37M | -1.34 | $350.02M |
| Dec 31, 2022 | $2.41B | $-13.66B | -84.60 | $189.29M |
| Dec 31, 2021 | $2.03B | $-428.79M | -2.73 | $193.99M |
Latest balance sheet: total assets $2.76B, total liabilities $1.45B, cash $774.35M (as of Jun 30, 2026).
TDOC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $9.18 |
| Apr 29, 2026 | 8-K Item 2.02 (results) | $5.95 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $4.65 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $8.23 |
| Oct 23, 2025 | 8-K Item 2.02 (results) | $8.60 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $7.53 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $7.19 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $10.99 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $8.86 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| Apr 25, 2024 | 8-K Item 2.02 (results) | — |
| Apr 5, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Offices & Clinics of Doctors of Medicine
Hims & Hers Health (HIMS)Starling Oncology (STLN)LifeMD (LFMD)Airsculpt Technologies (AIRS)Basel Medical (BMGL)SBC Medical (SBC)Auna (AUNA)Westin Acquisition (WSTN)Concord Medical Services (CCM)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TDOC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.